Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
CALL
Avantor
AVTR
$9.64B
| $256K | ﹤0.01% |
+15,800
| New | +$299K |
|
2702
Cogent Biosciences
COGT
$6.29B
| $256K | ﹤0.01% |
42,722
+25,903
| +154% | +$203K |
|
2703
dLocal
DLO
$4.45B
| $256K | ﹤0.01% |
+30,680
| New | +$346K |
|
2704
CALL
GSK
GSK
$104B
| $256K | ﹤0.01% |
6,600
+400
| +6% | +$14.6K |
|
2705
MetLife
MET
$61.1B
| $255K | ﹤0.01% |
+3,178
| New | +$264K |
|
2706
PUT
A.O. Smith
AOS
$8.52B
| $255K | ﹤0.01% |
+3,900
| New | +$264K |
|
2707
PUT
Chemours
CC
$2.32B
| $254K | ﹤0.01% |
+18,800
| New | +$312K |
|
2708
MongoDB
MDB
$32.4B
| $254K | ﹤0.01% |
1,448
-90,096
| -98% | -$22M |
|
2709
PUT
CoStar Group
CSGP
$13.3B
| $254K | ﹤0.01% |
3,200
-9,400
| -75% | -$715K |
|
2710
CALL
Terex
TEX
$7.53B
| $253K | ﹤0.01% |
+6,700
| New | +$293K |
|
2711
WEX
WEX
$6.93B
| $252K | ﹤0.01% |
1,608
-52,577
| -97% | -$8.66M |
|
2712
CALL
International Seaways
INSW
$4.95B
| $252K | ﹤0.01% |
+7,600
| New | +$278K |
|
2713
PUT
Comstock Resources
CRK
$4.19B
| $252K | ﹤0.01% |
+12,400
| New | +$238K |
|
2714
Mission Produce
AVO
$1.16B
| $252K | ﹤0.01% |
24,012
-11,248
| -32% | -$131K |
|
2715
Clean Energy Fuels
CLNE
$351M
| $251K | ﹤0.01% |
161,972
-184,831
| -53% | -$470K |
|
2716
CALL
LKQ Corp
LKQ
$6.51B
| $251K | ﹤0.01% |
+5,900
| New | +$234K |
|
2717
Warner Bros
WBD
$72B
| $251K | ﹤0.01% |
23,362
-248,409
| -91% | -$2.6M |
|
2718
Intuitive Surgical
ISRG
$132B
| $251K | ﹤0.01% |
+506
| New | +$280K |
|
2719
Corporacion America
CAAP
$3.9B
| $249K | ﹤0.01% |
+13,603
| New | +$257K |
|
2720
CALL
Equinor
EQNR
$101B
| $249K | ﹤0.01% |
9,400
-5,100
| -35% | -$124K |
|
|
STR
2721
DELISTED
Sitio Royalties
STR
| $249K | ﹤0.01% |
12,508
-94,107
| -88% | -$1.9M |
|
2722
CALL
Wheaton Precious Metals
WPM
$72.8B
| $248K | ﹤0.01% |
3,200
-5,300
| -62% | -$354K |
|
|
2723
CALL
A.O. Smith
AOS
$8.52B
| $248K | ﹤0.01% |
+3,800
| New | +$257K |
|
2724
Seadrill
SDRL
$2.92B
| $248K | ﹤0.01% |
9,931
-83,885
| -89% | -$2.6M |
|
2725
PUT
British American Tobacco
BTI
$122B
| $248K | ﹤0.01% |
6,000
-31,300
| -84% | -$1.23M |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.